Risk‐based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019
Pregnant women seeking routine MCH care were randomized into Universal (all received PrEP counseling and self-selected whether to initiate PrEP) or Targeted (HIV risk assessment to determine PrEP offer). There was no difference in maternal HIV incidence or frequency of appropriate PrEP use between arms. The researchers concluded that universal PrEP is best for integrating into MCH systems.
Resource Details
- Study Type
- Randomized clinical trial (RCT)
- Year
- 2023
- Population
- HIV-uninfected women, Pregnant Women
- Author
- Kinuthia J, Dettinger JC, Stern J, Ngumbau N, Ochieng B, Gómez L, Abuna F, Watoyi S, Marwa M, Odinga D, Wagner AD, Richardson BA, Pintye J, Baeten JM, John-Stewart G.
More Publications & Resources
Standard Operating Procedure for Injectable Lenacapavir as Pre-exposure Prophylaxis
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction
Rapid Landscape Analysis of National Vertical Transmission Policies for Inclusion of PrEP for Pregnant and Breastfeeding People
Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions
Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services
Oral PrEP for PBFP Training Package
Key Considerations for Integration of PrEP for Pregnant and Breastfeeding People into National Prevention of Vertical Transmission Polices
No results found.